|
Steven T. Wiersma, MD, MPH,
Bureau Chief,
State Epidemiologist

The Bureau
was cited
as the state’s
Outstanding
Work Unit
with a prize
of $2,500
Don Ward,
Deputy Chief,
Bureau of Epidemiology
Epi-Com will connect
more than 800 key
public health partners
with pivotal roles
in recognition and
intervention of
disease outbreaks.
Training component
modules will be
presented
in a two-day
distance learning satellite
videoconference on
December 5-6,
2002.
Phone Numbers
for Programs
Voice:
800-793-8598
FAX:
(800) 553-6323
TTY:
(800) 815-8152
Carina
Blackmore,
M.S. Vet. Med., Ph.D.
Higher flu activity
than expected for this
time of year (>2%)
was reported by
physicians in Duval,
Okaloosa and Polk counties
Caroline Collins,
Arbovirus Surveillance Coordinator
Lisa Conti, DVM, MPH
State Public Health Veterinarian
and D’Juan Harris,
GIS Coordinator
Disclaimer:
Please note that
numbers are subject
to change with
confirmatory information.
To
report dead birds use:
http://wildflorida.org/bird/
http://wld.fwc.state.fl.us/bird/
or call toll free 1-800-871-9703
|
|
►
Bureau of Epidemiology
Wins Top Award
The Davis Productivity Awards recognized the Bureau of Epidemiology with two performance awards for outstanding achievement in 2001.
Together with the Bureau of Laboratories, The Bureau of Epidemiology was cited as the state’s Outstanding Work Unit with a prize of $2,500 for outbreak response
efforts. The Bureau of Epidemiology also
received a letter of commendation for development of the Merlin project. The Davis Awards recognize and reward state government employees in Florida whose work significantly and measurably increases productivity and promotes innovation to improve the delivery of state services and save money for Florida taxpayers and businesses.
Rapid Response to Anthrax
The award was based in part on the rapid response of the Bureau of Epidemiology to the first case of intentionally-caused anthrax disease in the United States (Palm Beach County) that helped prevent further cases and deaths. Its investigation provided a model for response in other states and determined the source and mode of transmission within 3 and 7 days after the first case was confirmed.
Surveillance and Prevention of West Nile Virus
For the past two summers, Florida has experienced a new mosquito-borne and potentially fatal disease, the West Nile virus. The Bureau of Epidemiology team responded rapidly and effectively, resulting in prevention of many cases of severe disease, disability and death.
Certificate of Commendation Winner
The Bureau of Epidemiology, Merlin Development Team, won a Certificate of Commendation for creating Merlin, the state’s revolutionary disease reporting and analysis system, Merlin has replaced a slow, labor intensive paper-based reporting system with a web-based system that leads the state-of-the art for the nation. Merlin has added to the timeliness and accuracy of collecting and evaluating disease and laboratory information, enhancing the potential for rapid recognition and response to disease outbreaks, including potential bioterrorist events.
Back
to top
►
Epi-Com:
State-of-the-Art
Epidemiology Network
The State Technology Office (STO) has completed its technical review and the Bureau of Epidemiology is now cleared to complete development and activation of Epi-Com—a secure, web-based outbreak
communication/information network. When completed, the system will connect more than 800 key public health partners with pivotal roles in recognition and intervention of disease outbreaks including those related to a bioterrorist attack. Key partners include county health departments, state health offices, hospital emergency and infection control departments, clinical laboratories, major primary care providers, and a variety of responder groups.
The Epi-Com network will be similar in design to the CDC’s Epi-X, which uses a dedicated website for exchange of information among the state health departments and the CDC. Unlike Epi-X, EpiCom will extend the user community to the local level. Members will use the website to communicate about all levels of individual case, cluster, laboratory or other data related to an outbreak or to seek medical or epidemiologic
consultation. Members reading notices may respond with elucidating comments, guidance, anecdotal reports or criticisms. The network also will contain a step-down communications system to locate and inform key public health and response officials using pagers, telephones and other devices. The Bureau of Epidemiology will also provide an editing interface between the Florida network and the CDC’s Epi-X, to which the system will be connected, so posting of nationwide
interest can be easily migrated to the national system.
Back
to top
►
CDC
Bioterrorism Update: 12121
Smallpox Preparedness
A
National Immunization Program and
Public Health Training Network Satellite Broadcast
December
5, 2002 - Part 1
December 6, 2002 - Part 2
12:30 PM - 5:30 PM ET
Implementation of
a vaccination plan for smallpox preparedness and response will
require a variety of persons in state and local health departments,
hospitals, and other healthcare settings to receive general education and
training on smallpox and smallpox vaccine issues. Some personnel, e.g.
smallpox vaccine clinic personnel, clinicians who may evaluate and treat
adverse events, will need detailed information.
Hospital administrators and hospital-based
clinicians will need information to make informed decisions about
program participation and possible vaccination sequelae. Primary care
physicians will also need basic clinical information, including evaluation
of patients with rash/suspected smallpox, screening issues for potential
vaccinees who may seek their advice, and management and referral of
adverse reactions following vaccination.
Training component modules will be presented
in a two-day distance learning satellite videoconference on December 5-6,
2002. Modules of the 2-day program will be available in a variety of
formats including videotape, CD-ROMs, through the Centers for Disease
Control and Prevention (CDC) website and through print materials for
subsequent use. Public Health Foundation will distribute videos, CDs, and
selected print materials (free of charge) shortly after the program
broadcast.
Target Audience:
State/Local Public Health
Vaccine Program Implementers, Vaccine Clinic Personnel,
Clinicians/Healthcare Workers and Public Health Personnel Considering
Vaccine Program Participation, Clinicians/Healthcare Workers in Hospitals
Designated as Healthcare Response Teams, Front Line/Primary Care
Clinicians
Components (modules) of training needed
to support a smallpox vaccination program will include, but not be limited
to
Day 1
- Vaccine Clinic Operations and
Management
(site selection, setting up a clinic, scheduling, staffing)
- Vaccine Distribution and Storage
- Data and Information Management
- Laboratory Support
- Communications with Public and Stakeholders
- Considerations for Hospitals: Developing a Smallpox
Vaccine Healthcare Response Team
Day 2
- Vaccine Contraindications and
Screening
- Pre-screening of Program
Participants
- Vaccine Administration
- Vaccinee Education and Follow-up
Care: Evaluation of "Takes," Site Care, and Monitoring
- Vaccine Safety and Reporting
Adverse Events
- Evaluation, Management and
Treatment of Adverse Events of Smallpox Vaccine
Registration Information
Visit the CDC/ATSDR Training and
Continuing Education Online System at http://www.phppo.cdc.gov/phtnonline
to register online for these programs. Individual registration will
begin on Monday, December 2, 2002. No site registration will be
available for these programs.
You must use the on-line system to register
and complete the daily broadcast evaluations. A
certificate of attendance will be awarded to participants who complete a
course evaluation. Individuals who have questions about registration
should call 1-800-41-TRAIN or email ce@cdc.gov.
Modules of the 2-day program will be
available in a variety of formats including videotape, CD-ROMs, through
the Centers for Disease Control and Prevention (CDC) website and through
print materials for subsequent use.
The Public Health Foundation will
distribute videotapes, CD-ROMs, and selected print materials (free of
charge) shortly after these programs. Contact the Public Health Foundation
at http://www.phf.org or call toll free
1-877-252-1200.
Webcast Information
These programs will each have a live
webcast and will also be available for viewing after each live broadcast
via the CDC website, http://www.cdc.gov/smallpox.
Audiobridge Information
In the event you are unable to receive the
signal on program day, you may join by audiobridge.
Bridge will open at 11:45 AM ET
- USA Toll Free Number: 888-566-6189
- USA Toll Number 1-712-257-3328
-
Passcode for Dec. 5 - Part 1
broadcast:
If you have problems during your
audiobridge conference, you may call 800-728-8232 or International callers
dial 404-639-1289.
Back
to top
►
Influenza Virus Surveillance Summary Update
Week ending November 9, 2002-Week 45
Florida: During week 45 (November 3-9, 2002) influenza activity, calculated based on the proportion of patients with influenza-like illness (ILI) seeking care by physicians participating in the Florida Sentinel Physicians Surveillance Network was low 0.98%. Higher flu activity than expected for this time of year (>2%) was reported by physicians in Duval, Okaloosa and Polk counties. The third positive rapid flu test was reported from Miami-Dade County this week. Earlier this season an influenza A(H1N1) outbreak was confirmed in Holmes County.
National Report: One influenza B virus isolation was made from 738 specimens tested by the World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories this week. Since September 29, 0.2% (n=11) of the 6,493 specimens tested nationwide have been positive. Influenza A activity has been detected in Florida, Louisiana, New York, North Carolina and South Carolina. Influenza B isolates have been identified in New York, North Carolina and South Carolina. CDC has characterized one influenza A (H1N2) isolate antigenically. Both the hemagglutinin (H) and neuraminidase (N) proteins of this reassorted strain are similar to H and N proteins in the vaccine strains.
The proportion of patient visits to sentinel physicians for influenza-like illness (ILI) was 1.3% nationwide, which is below the national baseline of 1.9%. AN ILI outbreak was reported from Louisiana. Sporadic influenza activity was reported from 17 states (Alabama, Colorado, Florida, Georgia, Indiana, Kansas, Kentucky, Maine, Missouri, Nebraska, Nevada, New Mexico, Pennsylvania, Tennessee, Texas, West Virginia and Wyoming). The proportion of deaths attributed to pneumonia and influenza as reported by the vital statistics offices of 122 U.S. cities was 6.5% during week 45. This percentage is below the epidemic threshold of 7.2% for this time.
Back
to top
►
Arboviral Activity Summary Week Ending 11/258/02
There are Arbovirus
Medical Alerts issued by the State Health Officer for
37 counties: Alachua, Brevard, Charlotte, Citrus, Collier,
DeSoto, Escambia, Flagler, Glades, Hardee, Hendry, Hernando, Highlands,
Hillsborough, Indian River, Jackson, Lake, Lee, Levy, Manatee, Marion,
Martin, Okeechobee, Orange, Osceola, Palm Beach, Pasco, Pinellas, Polk,
Putnam, Santa Rosa, Sarasota, Seminole, St. Johns, St. Lucie, Sumter and
Volusia.
During
the period of November 19, 2002 through November 25, 2002, the following
arbovirus activity (St. Louis encephalitis [SLE] virus, eastern equine
encephalomyelitis [EEE] virus, West Nile [WN] virus and dengue virus) was
recorded for Florida:
Human:
One West Nile case was
reported this week, a 49 year-old resident of Hillsborough County.
Sentinel
Chickens:
Thirty-five WN seroconversions were confirmed in Bay (1), Charlotte
(2), Citrus (1), Hillsborough (1), Indian River (1), Lee (3), Manatee (3),
Martin (1), Okeechobee (1), Orange (6), Osceola (3), Palm Beach (2), Pasco
(2), Pinellas (1), Sarasota (2), Seminole (1), St. Johns (1), St. Lucie
(1), Volusia (1) and Walton (1) counties.
This week, 792 samples were tested from
24 counties.
Equine*:
Twenty-one WN cases were reported from the following counties:
Citrus (1), Escambia (4), Holmes
(3), Jackson (8), Pasco (1), Putnam
(1), Santa Rosa (2), and Washington (1).
Bird
Mortality:
Fourteen dead birds were reported with WN from Bay (1), Jackson (5),
Leon (1), Okaloosa (1), Pasco (2), Putnam (1), Santa Rosa (2) and
Walton (1) counties.
3,817
birds were tested and an additional 406 were too decomposed to be tested. To date, 9,523 bird reports were logged representing 11,833
dead birds; 1,204 (10%) were crows; 1,321 (11%) were blue jays and 286
(2%) were raptors.
To
report dead birds use http://wildflorida.org/bird/
or http://wld.fwc.state.fl.us/bird/
Online
bird identification: http://www.mbr-pwrc.usgs.gov/id/framlst/framlst.html
or http://data.acnatsci.org/ornithology/vireo.php
Mosquito
Pools:
No
new mosquito pools were reported WN positive this week.
A total of 3,512
mosquito pools collected during 2002 have been submitted for testing at
the DOH Tampa Laboratory.
At least 982 additional pools have been tested by mosquito control
agencies and 298 pools have been tested by Department of Defense
installations in the state.
Back
to top
►
Weekly Disease Table
: Week 45
Florida
Department of Health – Bureau of Epidemiology
Weekly Morbidity Report Selected
Diseases and Conditions
(Confirmed Cases Only) Week 46
Ending
11/16/2002
|
Disease |
2002
Week
46 |
2001
Total |
2000
To
Week
46 |
2001
To
Week
46 |
2002
To
Week
46 |
Average
For 2000
Through
2002
To Week46 |
2002
Percent
Change
From
Average |
|
Animal Bite, Pep Recommended |
14 |
1097 |
257 |
962 |
948 |
722.33 |
31 |
|
Animal Rabies |
0 |
157 |
146 |
153 |
37 |
112.00 |
-67 |
|
Anthrax |
0 |
2 |
0 |
2 |
0 |
0.67 |
-100 |
|
Botulism |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Brucellosis |
0 |
5 |
2 |
4 |
4 |
3.33 |
20 |
|
Campylobacteriosis |
20 |
881 |
842 |
783 |
857 |
827.33 |
4 |
|
Ciguatera |
2 |
12 |
14 |
9 |
7 |
10.00 |
-30 |
|
Cryptosporidiosis |
4 |
88 |
144 |
78 |
91 |
104.33 |
-13 |
|
Cyclosporiasis |
1 |
30 |
6 |
30 |
30 |
22.00 |
36 |
|
Dengue Fever |
1 |
8 |
1 |
5 |
11 |
5.67 |
94 |
|
Diphtheria |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Ehrlichiosis, Human |
0 |
7 |
3 |
3 |
2 |
2.67 |
-25 |
|
Encephalitis, Eastern Equine |
0 |
3 |
0 |
3 |
1 |
1.33 |
-25 |
Encephalitis,
Post-Infectious
|
0 |
10 |
12 |
9 |
14 |
11.67 |
20 |
Encephalitis,
St. Louis
|
0 |
0 |
0 |
0 |
2 |
0.67 |
200 |
|
Encephalitis, Venezuelan |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Encephalitis, West Nile Virus |
0 |
10 |
0 |
8 |
19 |
9.00 |
111 |
|
Encephalitis, Western Equine |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Escherichia Coli, O157:H7 |
0 |
44 |
85 |
40 |
53 |
59.33 |
-11 |
|
Escherichia Coli, Other |
1 |
17 |
9 |
16 |
17 |
14.00 |
21 |
|
Giardiasis |
20 |
1124 |
1189 |
950 |
1111 |
1,083.33 |
3 |
|
H. Influenzae Invasive Disease |
2 |
87 |
50 |
76 |
81 |
69.00 |
17 |
|
Hantavirus Infection |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Hemolytic Uremic Syndrome |
0 |
4 |
14 |
4 |
3 |
7.00 |
-57 |
|
Hemorrhagic Fever |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Hepatitis A |
6 |
809 |
436 |
642 |
931 |
669.67 |
39 |
|
Hepatitis B {+Hbsag in pregnant women} |
9 |
436 |
372 |
368 |
550 |
430.00 |
28 |
|
Hepatitis B Perinatal, Acute |
0 |
7 |
1 |
7 |
7 |
5.00 |
40 |
|
Hepatitis B, Acute |
11 |
493 |
406 |
414 |
464 |
428.00 |
8 |
|
Hepatitis B, Chronic |
8 |
479 |
0 |
333 |
447 |
260.00 |
72 |
|
Hepatitis C, Acute |
1 |
26 |
15 |
16 |
49 |
26.67 |
84 |
|
Hepatitis C, Chronic |
108 |
1005 |
0 |
857 |
2469 |
1,108.67 |
123 |
|
Hepatitis Nanb, Acute
|
0 |
6 |
6 |
6 |
4 |
5.33 |
-25 |
|
Hepatitis Unspecified, Acute |
0 |
6 |
7 |
4 |
1 |
4.00 |
-75 |
|
Human Rabies |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Lead Poisoning |
20 |
678 |
1023 |
552 |
866 |
813.67 |
6 |
|
Legionellosis |
2 |
96 |
40 |
81 |
72 |
64.33 |
12 |
|
Leprosy
{Hansens Disease}
|
0 |
1 |
3 |
1 |
4 |
2.67 |
50 |
|
Leptospirosis |
0 |
0 |
1 |
0 |
0 |
0.33 |
-100 |
|
Listeriosis |
2 |
19 |
34 |
17 |
25 |
25.33 |
-1 |
|
Lyme Disease |
0 |
54 |
44 |
52 |
71 |
55.67 |
28 |
|
Malaria |
0 |
59 |
64 |
46 |
60 |
56.67 |
6 |
|
Measles |
0 |
0 |
2 |
0 |
2 |
1.33 |
50 |
|
Meningitis, Other Bacterial |
1 |
174 |
192 |
142 |
174 |
169.33 |
3 |
|
Neurotoxic Shellfish Poisoning |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Other Vibrio Infections |
0 |
21 |
25 |
18 |
34 |
25.67 |
32 |
|
Pertussis |
0 |
22 |
45 |
21 |
33 |
33.00 |
0 |
|
Plague |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Rubella |
0 |
2 |
2 |
2 |
5 |
3.00 |
67 |
|
Rubella, Congenital |
0 |
0 |
1 |
0 |
0 |
0.33 |
-100 |
|
Salmonellosis |
127 |
3004 |
2324 |
2551 |
3806 |
2,893.67 |
32 |
|
Shigellosis |
61 |
909 |
1098 |
769 |
1677 |
1,181.33 |
42 |
|
Streptococcus Pneumoniae, Invasive Disease |
5 |
796 |
880 |
704 |
547 |
710.33 |
-23 |
|
Tetanus |
0 |
3 |
1 |
3 |
3 |
2.33 |
29 |
|
Toxoplasmosis |
0 |
34 |
10 |
26 |
27 |
21.00 |
29 |
|
Trichinosis |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Vibrio Vulnificus |
1 |
20 |
12 |
18 |
17 |
15.67 |
9 |
|
West Nile Virus Infection |
1 |
0 |
0 |
0 |
2 |
0.67 |
200 |
|
Yellow Fever |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Meningoccocal Disease |
2 |
117 |
95 |
108 |
96 |
99.67 |
-4 |
|
Mercury Poisoning |
1 |
2 |
9 |
2 |
7 |
6.00 |
17 |
|
Monkey Bite |
0 |
3 |
2 |
3 |
1 |
2.00 |
-50 |
|
Mumps |
0 |
7 |
3 |
4 |
6 |
4.33 |
38 |
|
Poliomyelitis |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Psittacosis |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Q Fever |
0 |
1 |
0 |
1 |
1 |
0.67 |
50 |
|
Rocky Mountain Spotted Fever |
0 |
3 |
1 |
3 |
7 |
3.67 |
91 |
|
Smallpox |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Staphylococcus Aureus {Gisa/Visa} |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Staphylococcus Aureus {Grsa/Vrsa} |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Streptococcal Disease Invasive Group A |
3 |
159 |
115 |
133 |
202 |
150.00 |
35 |
|
Tularemia |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Typhoid Fever |
0 |
12 |
10 |
10 |
19 |
13.00 |
46 |
|
Vibrio Cholerae Type O1 |
0 |
0 |
0 |
0 |
0 |
0.00 |
0 |
|
Vibrio Parahaemolyticus |
0 |
13 |
14 |
12 |
17 |
14.33 |
19 |
|